Related Experiment Videos
Effect of a hypocholesterolemic agent on cholesteryl ester metabolism in glioblastoma cells
Abstract:
The hypocholesterolemic agent 3 beta-(2-diethylaminoethoxy)androst-5-en-17-one . HCl (U18666A) is known to induce experimental epilepsy. The possibility that this drug interferes with cholesteryl ester formation in glioblastoma cells was examined. The incorporation of radioactive oleic acid into cellular cholesteryl ester was drastically and specifically inhibited by U18666A. The inhibitory effect of U18666A persisted in different oleic acid concentrations. Kinetic studies revealed the rapidity of U18666A action. U18666A was found to be ineffective in inhibiting acyl-CoA:cholesterol acyltransferase activity when it was added directly to the cell homogenates. In contrast, the acyltransferase activity was greatly diminished in homogenates derived from U18666A-treated cells. Thus, U18666A appeared to block cellular cholesteryl ester biosynthesis by indirectly inactivating acyl-CoA:cholesterol acyltransferase activity in a cell-dependent manner. The potent inhibition of cholesteryl ester formation by U18666A represents one unique aspect of the drug which might contribute to its ability to induce chronic epileptiform activity.
Insights
The drug U18666A, a hypocholesterolemic agent, significantly inhibits cholesteryl ester formation in glioblastoma cells. This inhibition occurs indirectly by affecting acyl-CoA:cholesterol acyltransferase activity, potentially linking to its epilepsy-inducing effects.
Area of Science:
- Biochemistry
- Cell Biology
- Neuropharmacology
Background:
- The hypocholesterolemic agent U18666A is known to induce experimental epilepsy.
- Cholesteryl ester formation is crucial for cellular lipid metabolism and function.
Purpose of the Study:
- To investigate the effect of U18666A on cholesteryl ester formation in glioblastoma cells.
- To elucidate the mechanism by which U18666A interferes with this process.
Main Methods:
- Treatment of glioblastoma cells with U18666A.
- Measurement of radioactive oleic acid incorporation into cellular cholesteryl esters.
- Assay of acyl-CoA:cholesterol acyltransferase activity in cell homogenates.
Main Results:
- U18666A drastically and specifically inhibited oleic acid incorporation into cholesteryl esters.
- The inhibitory effect was concentration-independent and rapid.
- U18666A indirectly inactivated acyl-CoA:cholesterol acyltransferase activity in a cell-dependent manner.
Conclusions:
- U18666A blocks cellular cholesteryl ester biosynthesis by indirectly inactivating acyl-CoA:cholesterol acyltransferase.
- This potent inhibition of cholesteryl ester formation may contribute to U18666A's epileptogenic properties.